In this context, the receptor tyrosine kinase-like orphan receptor 1 (ROR1) can be considered a putative TAA for CLL, being a cancer stem cell antigen almost exclusively expressed on tumor cells and involved in the biology and aggressiveness of the disease (228). The gene discussed is ROR1; the disease is neoplasm.